IP Library Patent Application 17544845
Patent Application
App. No. 17/544,845

USE OF A NEUROMODULATION SYSTEM

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
17/544,845
Abstract

A neuromodulation system can be used to treat a subject with at least one abnormal body function and/or disease comprising the treatment and/or modulation of at least one condition and/or function and/or dysfunction of the subject's gastrointestinal system, cardiovascular system, sensory system, urinary system, respiratory system, reproductive system, thermoregulation system and/or locomotor system.

Claims (22)

1 - 13 . (canceled)

14 . A method for treating a subject, the method comprising the treatment or modulation, using a neuromodulation system, of one or more of: a condition, a function, or a dysfunction of the subject's respiratory system .

15 . The method of claim 14 , wherein the at least one condition, function, or dysfunction comprises one or more of: bronchial tree obstruction, bronchial deficiency, or alveolar deficiency.

16 . The method of claim 14 , wherein the at least one condition, function, or dysfunction comprises one or more of: chronic obstructive pulmonary disease, a tumor, trauma, a stroke, a damaged dorsal root, a spinal cord injury, or amyotrophic lateral sclerosis (ALS).

17 . The method of claim 14 , wherein the treatment or modulation comprises providing stimulation at least partially to the level of C3-C5 of the subject to treat one or more of: dyspnea, spinal cord injury, or chronic obstructive pulmonary disease.

18 . The method of claim 14 , wherein the treatment or modulation comprises providing stimulation at least partially to the level of T1-T6 of the subject.

19 . The method of claim 14 , wherein the treatment or modulation comprises providing stimulation at least partially to the level of T7-T12 of the subject.

20 . The method of claim 14 , wherein the treatment or modulation comprises treating, or modulating an activity of, one or more of: bronchia, smooth muscles of the pulmonary system, nerve, alveoli, muscles, solitary tract, pulmonary circulation, or diaphragm.

21 . The method of claim 14 , wherein the treatment or modulation occurs throughout the rehabilitation process of the subject or during one or more stages of: stabilization in bed, mobilization in bed, mobilization at bedside, verticalization, stabilization of blood pressure, standing, stepping, balance training, locomotor training, fluent locomotion, pre-surgery, post-surgery, pre-implantation, post-implantation, post-setting of neuromodulation system, spinal shock, or daily life activities.

22 . The method of claim 14 , wherein the treatment or modulation further comprises the use of an assistive device, wherein the assistive device comprises one or more of: a breathing device, pulling handles, ceiling-mounted cables, aquatic equipment, a treadmill, an exoskeleton, an orthosis, a robot, a bike, a breather, crutches, a pressure cuff, a cuff for functional electrical stimulation, a smartwatch, a motorized mattress, non-invasive ventilation, a standing frame, a rollator, a body-weight support system, elastic bands, weights, a slide board, a step machine, a trike, a walker, a robot-physiotherapist, balls, or half-balls.

23 . The method of claim 14 , wherein the neuromodulation system is a neurostimulation system, the neurostimulation system comprises one or more of: an electrical neurostimulation system, a mechanical neurostimulation system, or a pharmacological neurostimulation system.

24 . The method of claim 23 , wherein the electrical neurostimulation system comprises one or more of: a dorsal root ganglion stimulation system, a subdural stimulation system, a transcutaneous electrical stimulation system, or an epidural electrical stimulation system.

25 . The method of claim 14 , wherein the neuromodulation system comprises one or more of: an open-loop system, closed-loop system, or pseudo-open-loop system.

26 . The method of claim 25 , wherein the closed-loop system comprises at least one sensor.

27 . The method of claim 26 , wherein the at least one sensor provides a quality or performance metric concerning the use of the neuromodulation system, the quality or performance metric comprising one or more of: a respiratory rate, a respiratory volume, a blood O2 saturation, or stress markers.

28 . The method of claim 26 , wherein the at least one sensor comprises one or more of: a plethysmography sensor, a thermometer, a pressure sensor, a pulse oximetry sensor, an inertial measurement unit (IMU), a goniometer, an insole, an electroencephalography sensor (EEG), or an electromyography sensor (EMG).

29 . The method of claim 14 , wherein the treatment or modulation, using the neuromodulation system, comprises providing, by the neuromodulation system, a neuromodulation signal configured to evoke a response.

30 . The method of claim 14 , wherein the treatment or modulation, using the neuromodulation system, comprises providing, by the neuromodulation system, one or more of:

tonic neuromodulation, burst neuromodulation, or high-frequency neuromodulation.

31 . The method of claim 14 , wherein the treatment or modulation, using the neuromodulation system, comprises providing, by the neuromodulation system, a frequency-modulated neuromodulation signal.

32 . The method of claim 31 , wherein a carrier wave of the frequency-modulated neuromodulation signal has a frequency within a range of 1 to 10 kHz.

33 . The method of claim 32 , wherein the frequency within a range of 5 to 10 kHz.

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 8, 2022
From: CABAN, MIROSLAV
To: ONWARD MEDICAL N.V.
Reel/Frame 061022/0508 →
CORRECTIVE ASSIGNMENT TO CORRECT THE THE TYPOGRAPHICAL ERROR THAT LISTED APPLICTION NO. 29/782, 452 INSTEAD OF APPLICATION NO. 29782,453 PREVIOUSLY RECORDED AT REEL: 058600 FRAME: 0518. ASSIGNOR(S) HEREBY CONFIRMS THE ASSIGNMENT. Recorded Mar 1, 2022
From: ONWARD MEDICAL B.V.
To: ONWARD MEDICAL N.V.
Reel/Frame 059280/0326 →
CHANGE OF NAME Recorded Dec 28, 2021
From: ONWARD MEDICAL B.V.
To: ONWARD MEDICAL N.V.
Reel/Frame 058600/0518 →